Plozasiran Notches Big Wins in Severe Hypertriglyceridemia
Treatment with plozasiran (Redemplo) significantly reduced triglycerides among patients with severe hypertriglyceridemia, two phase III studies showed. Compared with placebo, the small interfering RNA therapy reduced triglycerides by 79% in…
